GCG and Down syndrome: Co-labelling with antibodies against smooth muscle actin to mark the spleen vasculature (Fig. 1p,q and Supplementary Fig. 2a,b), and insulin and glucagon to identify pancreatic islets (Fig. 1s,t and Supplementary Fig. 2f,g), showed no overall disruptions in tissue morphology in the Down syndrome samples.